Decoy Therapeutics (DCOY) Change in Inventory (2016 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Change in Inventory of $54831.0 for Q3 2019, down 60.61% year-over-year from $139206.0 in Q3 2018, and up 262.81% quarter-over-quarter from -$33677.0 in Q2 2019.
Decoy Therapeutics (DCOY) Change in Inventory (2016 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Change in Inventory for 4 consecutive years, with $54831.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Change in Inventory fell 60.61% year-over-year to $54831.0; the TTM figure through Dec 2020 stood at $21154.0 (up 1909.58% YoY), while the FY2019 annual figure was -$1169.0, changed N/A from the prior year.
- Change in Inventory grew to $54831.0 in Q3 2019 per DCOY's latest filing, from -$33677.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $344431.0 in Q4 2016 and bottomed at -$167253.0 in Q2 2017.
- Historically, Change in Inventory has averaged $30765.9 across 4 years, with a median of -$9513.0 in 2018.
- Annual changes were most pronounced in 2017 — Change in Inventory jumped 274.32% — and 2019, when it slumped 777.07%.
- Decoy Therapeutics' Change in Inventory stood at $344431.0 in 2016, then slumped by 129.64% to -$102105.0 in 2017, then jumped by 236.34% to $139206.0 in 2018, then plunged by 60.61% to $54831.0 in 2019.
- Business Quant data shows DCOY's Change in Inventory at $54831.0 in Q3 2019, -$33677.0 in Q2 2019, and -$22323.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | - |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 54,831.00 |
| Sep 30, 2019 | 54,831.00 |
| Jun 30, 2019 | -33,677.00 |
| Jun 30, 2019 | -33,677.00 |
| Mar 31, 2019 | -22,323.00 |
| Mar 31, 2019 | -22,323.00 |
| Sep 30, 2018 | 139,206.00 |
| Sep 30, 2018 | 139,206.00 |
| Jun 30, 2018 | -142,503.00 |
| Jun 30, 2018 | -142,503.00 |
| Mar 31, 2018 | 3,297.00 |
| Mar 31, 2018 | 3,297.00 |
| Dec 31, 2017 | -102,105.00 |
| Dec 31, 2017 | -102,105.00 |
| Sep 30, 2017 | 286,927.00 |
| Sep 30, 2017 | 286,927.00 |
| Jun 30, 2017 | -167,253.00 |
| Jun 30, 2017 | -167,253.00 |
| Mar 31, 2017 | -39,810.00 |
| Mar 31, 2017 | -39,810.00 |